Shingles Vaccine in Edinburgh
If you are considering protection against shingles, an appointment at Edinburgh Vaccination Clinic can help confirm whether vaccination is appropriate for you. We provide personalised advice and offer the Shingles vaccine for suitable patients seeking private protection. Read our comprehensive guide on Shingles here.
Shingles, also known as herpes zoster, is caused by reactivation of the varicella-zoster virus, the same virus that causes chickenpox. The risk of shingles increases with age and can also be higher in people with weakened immune systems. Vaccination is an effective way to reduce the risk of shingles and complications such as post-herpetic neuralgia, the persistent nerve pain that can follow the rash. Current UK guidance uses Shingrix®, a recombinant, non-live vaccine, as the routine shingles vaccine.
For many patients, private shingles vaccination offers a convenient way to arrange protection promptly, particularly if they want clarity on eligibility, previous vaccine history, or the most suitable timing for vaccination.
What is Shingles?
Shingles is a condition caused by reactivation of latent varicella-zoster virus in someone who has had chickenpox in the past. The virus remains dormant in the body and can reactivate later, producing a painful rash, typically affecting one side of the body or face. In some people, shingles can lead to longer-lasting nerve pain and other complications.
From a practical healthcare perspective, the main value of vaccination is that it helps reduce the chance of developing shingles in the first place and lowers the risk of troublesome complications if shingles does occur.
What are the symptoms of Shingles?
Shingles commonly causes:
- pain, burning, tingling, or sensitivity in an area of skin
- a blistering rash, usually on one side of the body
- headache
- feeling generally unwell
- discomfort that may persist after the rash has settled in some cases
Many people recognise shingles by the combination of pain and a one-sided blistering rash. For most patients considering vaccination, the more relevant issue is preventing shingles and reducing the chance of lingering nerve pain.
Who may benefit from Shingles vaccination?
Shingles vaccination may be particularly relevant for:
- older adults
- people with certain forms of severe immunosuppression
- adults who want to reduce their future risk of shingles and post-herpetic neuralgia
- people who have had shingles before and want to discuss whether vaccination is still appropriate
Current UK programme guidance offers 2 doses of Shingrix® to immunocompetent adults at eligible ages and to severely immunosuppressed adults aged 18 and over. The programme has been widening, with immunocompetent eligibility moving through age cohorts and severely immunosuppressed adults eligible from age 18.
In private practice, shingles vaccination is also commonly considered by adults outside the routine NHS invitation point who want protection and are clinically suitable. That can be especially relevant for people aged 50 and over, since Shingrix is licensed for prevention of shingles in adults aged 50 and over and in adults aged 18 and over at increased risk.
Important note about Shingles protection
One of the most useful points for patients is that the current shingles vaccine used in UK practice, Shingrix®, is a non-live vaccine. That is important because it means it can be used in many people for whom older live shingles vaccines were unsuitable.
It is also important to know that private shingles vaccination is not only for people who have never had shingles. People who have had shingles before may still be considered for vaccination after appropriate assessment, because previous shingles does not guarantee lifelong protection against recurrence.
About the Shingles vaccine
The shingles vaccine currently used in UK guidance is Shingrix®, a recombinant, adjuvanted, non-live vaccine. It is given as a 2-dose course. For immunocompetent adults, the second dose is usually given 6 to 12 months after the first. For severely immunosuppressed individuals, the second dose can be given after a shorter interval, with a minimum of 8 weeks between doses.
Important practical points include:
- it is given by injection
- 2 doses are needed for full protection
- it is a non-live vaccine
- it is used to reduce the risk of shingles and post-herpetic neuralgia
There is no routine recommendation to restart the course if the interval between doses is longer than planned; the second dose can still be given to complete the course.
Who should not have the Shingles vaccine?
There are very few people who cannot receive Shingrix®. As with most vaccines, it may need to be postponed if someone is currently significantly unwell with a fever, and it may not be appropriate for someone who has had a severe allergic reaction to a previous dose or vaccine ingredient.
At your appointment, we can review your medical background, previous shingles history, and current medicines to confirm whether shingles vaccination is suitable for you.
How is Shingles spread?
Shingles itself is not passed from one person to another as shingles. However, the varicella-zoster virus can be transmitted from the fluid in shingles blisters to someone who has never had chickenpox or has not been vaccinated against it, potentially causing chickenpox in that person. This spread is mainly through direct contact with blister fluid.
Vaccination helps reduce the chance of developing shingles and therefore also reduces the chance of complications associated with reactivation of the virus.
Shingles vaccine appointments in Edinburgh
At Edinburgh Vaccination Clinic, we offer shingles vaccine appointments for patients who want to review or arrange protection against shingles. This may be especially useful for older adults, those with relevant medical risk factors, and people who want quick, clear advice on whether they are suitable for private vaccination.
Your appointment may include:
- review of your vaccine history
- advice on whether shingles vaccination is appropriate
- confirmation of the most suitable timing for each dose
- discussion of previous shingles episodes and current medical background
- guidance on any other relevant adult vaccines where appropriate
Side effects of the Shingles vaccine
The shingles vaccine is generally well tolerated. Most side effects are mild to moderate and short-lived.
Possible side effects can include:
- pain, redness, or swelling at the injection site
- tiredness
- muscle aches
- headache
- mild fever or feeling flu-like for a short time
These effects usually settle within a few days. Because Shingrix is a non-live vaccine, it does not cause a varicella-like rash in the way a live vaccine might.
Frequently asked questions
Is the Shingles vaccine one dose or two?
The current shingles vaccine used in UK guidance, Shingrix®, is given as 2 doses.
Is the Shingles vaccine live?
No. Shingrix® is a recombinant, non-live vaccine.
Can I have the Shingles vaccine if I have had shingles before?
Often, yes. Having had shingles before does not automatically mean vaccination is unnecessary, and suitability can be assessed individually.
Can people with weakened immune systems have the Shingles vaccine?
Many can, because Shingrix® is non-live. Current UK guidance includes severely immunosuppressed adults aged 18 and over in the shingles programme.
How long does the Shingles vaccine protect for?
Current guidance supports strong ongoing protection after the full course. UK programme materials emphasise completing both doses for full protection.
When should I book my appointment?
It is best to arrange vaccination as soon as convenient if you are considering private shingles protection, especially if you want to complete both doses in a timely way.
Book a Shingles vaccine consultation in Edinburgh
If you would like to review or arrange protection against shingles, book an appointment with Edinburgh Vaccination Clinic. We will review your history, confirm whether vaccination is appropriate, and help you arrange the most suitable course for you.
